[ Title ]
- The development of the first line treatment of metastatic colorectal cancer (mCRC)]
[ Author ]
- L. Landherr and T. Nagykalnai
[ Abstract ]
- Chemotherapy options of metastatic colorectal cancer (mCRC) have been progressed rapidly in the last years. Besides of the standard fluorouracil/folinic acid treatment some new active agents (oxaliplatin and irinotecan) have been introduced, and more recently the "targeted" biologicals (bevacizumab, cetuximab, panitumumab) have demonstrated their high effectiveness. This review summarizes the development of the first line treatment of mCRC.
[ URL ]
- http://www.ncbi.nlm.nih.gov/pubmed/19793687